Ausgabe 2/2025
Inhalt (7 Artikel)
The Importance of Including Underserved Populations in Research
- Leading Article
Kayla R. Mehl, Stephanie R. Morain, Emily A. Largent
Innovation in the Design of Clinical Trials for Infectious Diseases: Focusing on Patients Over Pathogens
- Open Access
- Current Opinion
John H. Powers III, Robert J. O’Connell
Visionary Health Architects and Leaders: The Strategic Role of Medical Advisors in Modern Pharma
- Current Opinion
Selene García-García, Joan Rius-Tarruella
Disproportionality Analysis and Causal Inference in Drug Safety
- Current Opinion
Emil Scosyrev, Sigrid Behr, Devendra Jain, Arun Ponnuru, Christiane Michel
The Economic Impact of Reliance on an African Medicines Regulatory Authority
- Open Access
- Original Research Article
Lorraine Danks, Boitumelo Semete-Makokotlela, Regardt Gouws, Kennedy Otwombe, Stuart Walker, Sam Salek
Suggested Improvements to the Current East African Community Medicines Regulatory Harmonization Joint Review Process and a Proposed New Review Model for this Initiative
- Open Access
- Original Research Article
Nancy Ngum, Chimwemwe Chamdimba, Dedith Mbonyingingo, Fred Siyoi, Emile Bienvenu, Mawien Atem, Adam Fimbo, David Nahamya, Burhani Simai, Stuart Walker, Sam Salek
Compliance with Cyproterone Contraindications and Meningioma Risk: Resource-Efficient Use of Aggregated Statistics from Swedish National Health Registers
- Research Letter
Karl Mikael Kälkner, Anders Sundström, Rickard Ljung
